33

Vuno Inc.

338220 · KQ · Healthcare / Health Information Services

5,470.00KRW-40.00 (-0.73%)

Price History

Full chart

Market Stats

Previous Close5,510.00
Open5,660.00
Day Range5,330.00 – 5,940.00
52-Week Range4,235.00 – 28,350.00
Volume97.20K
Market Cap116.92B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.99
50-Day Avg6,650.60
200-Day Avg13,364.50

About

Vuno Inc. engages in the artificial intelligence medical software development and services business. The company provides medical AI solutions for analyzing various medical data and assisting in disease diagnosis. It also offers BoneAge, an AI diagnostic software for bone age assessment; DeepBrain, a brain parcellation for the quantitative analysis of neurodegenerative diseases and other neurological disorders; chest X-ray, a diagnostic support system for abnormalities in chest x-ray; fundus AI, an AI-based screening solution for various abnormalities in the fundus of the eye; DeepCARS, an AI-based cardiac arrest risk management system; and LungCT AI, an AI-based pulmonary lung nodule detection and reporting system. In addition, the company provides medical products under HATIV brand, such as HATIV K30, a kiosk-type medical device that measures electrocardiograms; HATIV P30, a medical ECG device; HATIV BP30, an automatic blood pressure monitoring device; and HATIV TP50T, an ear infrared thermometer device. The company was founded in 2014 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Ye-ha Lee
  • Employees146
  • Headquarters479, Gangnam-daero, Seoul, South Korea, 06536, Korea
  • Websitehttps://www.vuno.co

Leadership

  • Mr. Ye-ha LeeCEO & Executive Director · b. 1978
  • Mr. JunHong KimCFO & Head of Management · b. 1969
  • Mr. SeongHoon JooChief Technology Officer · b. 1990

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue161.80M82.35M162.10M1.26B2.25B8.27B13.28B25.87B34.85B
Growth (%)--49.10%+96.83%+675.59%+78.80%+268.10%+60.44%+94.86%+34.71%
Cost of Revenue---17.70M37.80M324.59M638.61M1.10B882.32M796.15M
Gross Profit--179.80M1.22B1.92B7.64B12.18B24.99B34.05B
Gross Margin--110.92%96.99%85.56%92.28%91.72%96.59%97.72%
Operating Expense--6.20B10.94B21.72B23.00B31.08B37.44B38.99B
Operating Income-912.64M-2.67B-6.02B-9.72B-19.79B-15.37B-18.91B-12.45B-4.93B
Operating Margin-564.06%-3243.67%-3714.89%-773.27%-880.51%-185.71%-142.42%-48.13%-14.16%
EBITDA------13.92B-13.33B-10.91B-3.69B
EBITDA Margin------168.23%-100.40%-42.17%-10.58%
Net Income-862.11M-5.75B-5.91B-11.11B-19.56B-15.66B-15.63B-13.02B-5.78B
Net Income Margin-532.82%-6984.29%-3647.52%-883.59%-869.96%-189.28%-117.71%-50.32%-16.58%
R&D---2.40B5.07B4.85B4.65B5.27B5.91B
R&D as % of Total Revenue---191.01%225.61%58.57%35.06%20.37%16.95%
Interest Expense00053.81M132.80M369.05M879.69M581.37M418.22M
Interest Expense % of Total Revenue0.00%0.00%0.00%4.28%5.91%4.46%6.63%2.25%1.20%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.66B12.47B7.45B9.59B35.61B35.38B22.56B50.18B50.39B
Total Liabilities8.38B1.50B2.03B13.23B13.01B16.69B17.54B19.49B14.27B
Total Equity-5.72B10.98B5.42B-3.64B22.59B18.69B5.02B30.69B36.11B
Cash489.69M2.28B4.01B1.69B5.14B10.13B4.69B6.85B5.55B
Net Debt---2.51B--3.66B2.97B1.43B

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-873.12M-1.75B-4.87B-7.80B-14.80B-16.28B-15.55B-10.86B-4.68B
Investing Cash Flow378.14M-8.04B6.83B-4.19B-18.32B6.90B7.37B19.44M-
Financing Cash Flow44.55M11.57B-226.93M9.66B36.52B14.35B2.78B12.87B-
Capital Expenditure74.61M120.18M715.13M321.07M1.29B312.51M382.36M1.11B1.07B
Free Cash Flow----8.38B-16.41B-16.59B-15.93B-11.96B-5.75B
FCF to OCF---107.45%110.91%101.92%102.46%110.19%122.87%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------
EPS Actual-640.66-398.74-397.40-394.35-516.60-494.43-404.9529.92-375.51-231.98-197.08-538.13-284.49-233.72-206.89-220.55-234.82-58.2167.38-193.54-284.82-384.51
Surprise----------------------
Timing----------------------

Key Statistics & Ratios

Market Cap116.92B
Enterprise Value53.08B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.87
Price / Book2.19
Revenue (TTM)30.22B
Gross Profit (TTM)29.35B
EBITDA-7.78B
Profit Margin-36.56%
Operating Margin-68.87%
Return on Equity-35.50%
Return on Assets-13.19%
Shares Outstanding14.00M
Shares Float11.80M
Beta0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%